Tinnitus
A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.
Drugs by status
Approved for this indication (1)
Phase 4 trials (18)
Phase 3 trials (5)
Phase 2 trials (16)
Phase 1 trials (5)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (24)
- Novartis
- Autifony Therapeutics Limited
- Bayer
- GlaxoSmithKline
- Otonomy, Inc.
- United States Army
- University of Illinois
- University of Arizona
- Azad University
- Mashhad University of Medical Sciences
- Southern Illinois University
- Sheffield Hallam University
- Tinnitus Research Consortium
- University of Iowa
- University of Miami
- University of Nottingham
- Wayne State University
- Columbia University
- University of Ulm
- St Joseph University
- Sound Pharmaceuticals
- St Joseph University of Beirut
- Ludwig Maximilians University
- Department of Veteran Affairs
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (12)